Purchase Order SPE2DS26P0264
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation for defibrillator and monitor equipment, with a completion date of September 26, 2025. The award was made on July 28, 2025, with no small business set-aside applied. Zoll Medical Corporation, a foreign-owned medical device manufacturer headquartered in Chelmsford, Massachusetts, will perform this work at its Chelmsford facility. The company specializes...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price purchase order valued at $6,962.34 to Zoll Medical Corporation for defibrillator and monitoring equipment on July 21, 2025. The contract, with an ultimate completion date of September 19, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was not designated as a set-aside contract and represents a routine procurement action typical of DLA's ongoing medical equipment supply...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation on July 18, 2025, for defibrillator/monitor equipment. The contract, with an ultimate completion date of September 16, 2025, will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was not set aside for any specific business designation and represents a continuation of Zoll's substantial role as a critical medical...
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation for defibrillator and monitor equipment. The contract was awarded on July 18, 2025, with an ultimate completion date of September 16, 2025, and will be performed at Zoll's facility in Chelmsford, Massachusetts. This award was made without a set-aside designation for small or disadvantaged businesses. Zoll Medical Corporation, a foreign-owned medical device...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation for defibrillator/monitor equipment. The contract, issued on July 17, 2025, carries an ultimate completion date of September 15, 2025, with performance taking place at Zoll's facility in Chelmsford, Massachusetts. No set-aside designation was applied to this award. Zoll Medical Corporation, a foreign-owned medical device...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation for defibrillator and monitor equipment. The contract, issued on July 18, 2025, with completion targeted for September 16, 2025, represents a standard procurement action with no set-aside designation. Performance will take place at Zoll's facility in Chelmsford, Massachusetts. This award leverages Zoll's existing contractual...
- The Defense Logistics Agency (DLA), through its Medical Supply Chain division, awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation on July 22, 2025, for a defibrillator/monitor system. The contract, which carries an ultimate completion date of September 22, 2025, will be performed in Chelmsford, Massachusetts, where Zoll maintains its headquarters. This award was not set aside for any specific business designation. Zoll Medical Corporation, a foreign-owned medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $335,871.10 firm fixed-price delivery order to Zoll Medical Corporation on September 23, 2025, with completion expected by September 26, 2025. The contract, identified as 4569553422, calls for the delivery of monitoring versus preparation equipment including 12 lead defibrillators, NIBP (non-invasive blood pressure) monitors, and associated CP2 components to be performed at Zoll's facility in Chelmsford, Massachusetts....
- The U.S. Department of Defense Medical Supply Chain awarded a $1,295 firm fixed-price purchase order to Zoll Medical Corporation for an automated defibrillator on August 8, 2025, with an ultimate completion date of October 7, 2025. The contract was not set aside for small business or other designated categories. Zoll Medical Corporation, headquartered in Chelmsford, Massachusetts, is a foreign-owned medical device manufacturer specializing in emergency medical technologies and critical care...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $2,115 firm fixed-price purchase order to Zoll Medical Corporation on September 17, 2025, with an ultimate completion date of November 17, 2025. The contract, which was not set aside for any specific business designation, will be performed at Zoll's headquarters in Chelmsford, Massachusetts. Zoll Medical Corporation, a foreign-owned medical device manufacturer, is a primary supplier of advanced emergency medical...
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $6,962.34 firm fixed-price purchase order to Zoll Medical Corporation for defibrillator and monitoring equipment, with a completion deadline of December 29, 2025. This contract, issued on October 30, 2025, represents a competitive award without set-aside designation and specifies Chelmsford, Massachusetts as the place of performance. Zoll Medical Corporation, a foreign-owned medical device manufacturer specializing in emergency medical technologies and critical care solutions, serves as the prime contractor and sole vendor on this award. This procurement exemplifies Zoll's established role as a cornerstone supplier within the federal medical equipment procurement ecosystem. The company maintains substantial contractual authority to fulfill urgent medical supply requirements, supported by an $81 million Indefinite Delivery Contract with DLA Troop Support Medical and a $23.4 million Federal Supply Schedule agreement with the Department of Veterans Affairs through December 2029. Zoll's comprehensive product portfolio includes automated external defibrillators, patient monitoring systems such as PROPAQ vital signs monitors, and associated components, positioning the company to rapidly respond to defense and civilian healthcare system requirements across multiple federal agencies including the Department of Veterans Affairs, Department of Homeland Security, and Department of State.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 10/30/25 |